Company Overview - Evolv Technologies Holdings operates at the intersection of security and artificial intelligence, providing scalable, touchless screening solutions for public venues, addressing the demand for efficient security in high-traffic environments [1] - The company generates revenue through hardware sales, software subscriptions, and analytics platforms that offer security insights and operational data to clients [2] Recent Financial Performance - In the third quarter, revenue increased by 57% year over year to $42.9 million, while annual recurring revenue rose by 25% to $117.2 million [8] - Adjusted EBITDA turned positive at $5.1 million, and management raised full-year 2025 revenue guidance to between $142 million and $145 million, indicating potential growth of up to 40% [8] Insider Transactions - John Kedzierski, the president and CEO, sold 74,322 shares at $7.03 per share, totaling approximately $522,483.66, following the exercise of 207,000 options [4][5] - The sale reduced Kedzierski's direct ownership by 34.57%, from 215,000 to 140,678 shares, with no indirect holdings reported post-transaction [3][5] - The transaction was executed to cover withholding taxes from the vesting of restricted stock units, rather than indicating a reduction in conviction [7][9]

Company Overview - Evolv Technologies provides AI-based touchless security screening systems designed to detect firearms, improvised explosive devices, and tactical knives as visitors walk through at a normal pace [5][8] - The company generates revenue through the sale and subscription of hardware and software solutions for security screening, analytics, and visitor management, serving sectors such as entertainment, education, healthcare, and other public spaces [8] Financial Performance - As of November 20, 2025, Evolv Technologies had a market capitalization of $987.46 million, with a revenue of $136.50 million and a net income of -$59.74 million for the trailing twelve months (TTM) [4] - In the most recent quarter, sales grew by 57%, and annual recurring revenue increased by 25%, with management expecting to generate positive operating cash flows in the upcoming quarter [11] Investment Position - Mittelman Wealth Management initiated a new position in Evolv Technologies, acquiring 1,511,866 shares valued at $11.41 million, representing a 7.47% allocation of the fund's $152.74 million in reportable U.S. equity assets [2][3] - Evolv Technologies has become the sixth-largest position for Mittelman Wealth Management, indicating strong institutional interest in the stock [9] Market Performance - As of November 20, 2025, Evolv's shares were priced at $5.66, reflecting a 107.0% increase over the past year, significantly outperforming the S&P 500 by 97 percentage points [3] - The stock is trading at 7 times sales, which is comparatively lower than a peer like Axon Enterprise, which trades at 16 times sales, suggesting a potentially attractive investment opportunity [11]